262 related articles for article (PubMed ID: 15694126)
1. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site.
Akiyama H; Kamitani T; Yang X; Kandyil R; Bridgewater LC; Fellous M; Mori-Akiyama Y; de Crombrugghe B
Matrix Biol; 2005 Jan; 23(8):499-505. PubMed ID: 15694126
[TBL] [Abstract][Full Text] [Related]
2. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
[TBL] [Abstract][Full Text] [Related]
3. PIAS1 interacts with and represses SOX9 transactivation activity.
Oh HJ; Kido T; Lau YF
Mol Reprod Dev; 2007 Nov; 74(11):1446-55. PubMed ID: 17440973
[TBL] [Abstract][Full Text] [Related]
4. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter.
Pan Q; Yu Y; Chen Q; Li C; Wu H; Wan Y; Ma J; Sun F
J Cell Physiol; 2008 Oct; 217(1):228-41. PubMed ID: 18506848
[TBL] [Abstract][Full Text] [Related]
5. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9.
Xie WF; Zhang X; Sakano S; Lefebvre V; Sandell LJ
J Bone Miner Res; 1999 May; 14(5):757-63. PubMed ID: 10320524
[TBL] [Abstract][Full Text] [Related]
6. The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity.
Baert JL; Beaudoin C; Monte D; Degerny C; Mauen S; de Launoit Y
Oncogene; 2007 Jan; 26(3):415-24. PubMed ID: 16832340
[TBL] [Abstract][Full Text] [Related]
7. A 30-base-pair element in the first intron of SOX9 acts as an enhancer in ATDC5.
Morishita M; Kishino T; Furukawa K; Yonekura A; Miyazaki Y; Kanematsu T; Yamashita S; Tsukazaki T
Biochem Biophys Res Commun; 2001 Oct; 288(2):347-55. PubMed ID: 11606049
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.
James CG; Woods A; Underhill TM; Beier F
BMC Mol Biol; 2006 Sep; 7():30. PubMed ID: 16984628
[TBL] [Abstract][Full Text] [Related]
9. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
10. SOX9 determines RUNX2 transactivity by directing intracellular degradation.
Cheng A; Genever PG
J Bone Miner Res; 2010 Dec; 25(12):2680-9. PubMed ID: 20593410
[TBL] [Abstract][Full Text] [Related]
11. Oligonucleotide decoy mimicking alphaA-crystallin-binding protein 1 binding site on mouse Col2a1 enhancer stimulates transcription from the adjacent Col2a1 promoter in chondrogenic ATDC5 cell.
Yamagiwa H; Yamada Y; Bolander ME; Sarkar G
Mol Biotechnol; 2004 Sep; 28(1):1-8. PubMed ID: 15456958
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9.
Robins JC; Akeno N; Mukherjee A; Dalal RR; Aronow BJ; Koopman P; Clemens TL
Bone; 2005 Sep; 37(3):313-22. PubMed ID: 16023419
[TBL] [Abstract][Full Text] [Related]
13. The homeobox transcription factor Barx2 regulates chondrogenesis during limb development.
Meech R; Edelman DB; Jones FS; Makarenkova HP
Development; 2005 May; 132(9):2135-46. PubMed ID: 15800003
[TBL] [Abstract][Full Text] [Related]
14. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis.
Amarilio R; Viukov SV; Sharir A; Eshkar-Oren I; Johnson RS; Zelzer E
Development; 2007 Nov; 134(21):3917-28. PubMed ID: 17913788
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the human Sox9 promoter by the CCAAT-binding factor.
Colter DC; Piera-Velazquez S; Hawkins DF; Whitecavage MK; Jimenez SA; Stokes DG
Matrix Biol; 2005 May; 24(3):185-97. PubMed ID: 15908194
[TBL] [Abstract][Full Text] [Related]
16. Serine racemase suppresses chondrogenic differentiation in cartilage in a Sox9-dependent manner.
Takarada T; Hinoi E; Takahata Y; Yoneda Y
J Cell Physiol; 2008 May; 215(2):320-8. PubMed ID: 17929246
[TBL] [Abstract][Full Text] [Related]
17. Long-range upstream and downstream enhancers control distinct subsets of the complex spatiotemporal Sox9 expression pattern.
Bagheri-Fam S; Barrionuevo F; Dohrmann U; Günther T; Schüle R; Kemler R; Mallo M; Kanzler B; Scherer G
Dev Biol; 2006 Mar; 291(2):382-97. PubMed ID: 16458883
[TBL] [Abstract][Full Text] [Related]
18. Involvement of nuclear factor I transcription/replication factor in the early stage of chondrocytic differentiation.
Uchihashi T; Kimata M; Tachikawa K; Koshimizu T; Okada T; Ihara-Watanabe M; Sakai N; Kogo M; Ozono K; Michigami T
Bone; 2007 Dec; 41(6):1025-35. PubMed ID: 17904922
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5.
Hattori T; Coustry F; Stephens S; Eberspaecher H; Takigawa M; Yasuda H; de Crombrugghe B
Nucleic Acids Res; 2008 May; 36(9):3011-24. PubMed ID: 18390577
[TBL] [Abstract][Full Text] [Related]
20. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
